Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate whether bepotastine besilate ophthalmic solution is effective in the treatment of acute allergic conjunctivitis

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bausch & Lomb Incorporated
• Treatments: Bepotastine besilate; Ophthalmic Solutions; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• At least 10 years of age & either sex, any race

• Willing and able to follow all instructions and attend all study visits

• Positive history of ocular allergies

Exclusion Criteria:

• Have planned surgery during trial period

• Female currently pregnant, planning a pregnancy, or lactating